Buy Ranbaxy Labs, target of Rs 620-630: Vivek Kumar

Vivek Kumar, SBI Cap Securities advice traders to buy Ranbaxy Labs for target of Rs 620-630.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney IThe Winning Leap SME Special
Moneycontrol

Home » News » Stocks Views

Nov 08, 2012, 07.03 PM | Source: CNBC-TV18

Buy Ranbaxy Labs, target of Rs 620-630: Vivek Kumar

Vivek Kumar, SBI Cap Securities advice traders to buy Ranbaxy Labs for target of Rs 620-630.

Like this story, share it with millions of investors on M3

Buy Ranbaxy Labs, target of Rs 620-630: Vivek Kumar

Vivek Kumar, SBI Cap Securities advice traders to buy Ranbaxy Labs for target of Rs 620-630.

Post Your Comments

Share Cancel

Vivek Kumar (more)

, SBI Cap Securities | Capital Expertise: Equity - Fundamental

Vivek Kumar, SBI Cap Securities advice traders to buy Ranbaxy Labs for target of Rs 620-630.

Kumar told CNBC-TV18, “Most of the worst is behind for the Ranbaxy at this point in time and given the near-term triggers in the form of techno launches which is scheduled for December end, some of the positive commentary coming on.”

He further added, “This stock is not being purely valued at this point in time. So I think you can still look at stocks running upto Rs 620-630 and that is where I think we are looking at in terms of the target price and we still have a buy rating on this stock.”

“Sun Pharmaceutical has also delivered quite strong numbers because if I look at the margins, they have delivered more than 43 percent, I think street was also around 41 percent and we were expecting around 42 percent, so I believe overall on the topline also they have delivered in excess of 20 percent kind of growth and it is still going to be taking in terms of a positive thing by the street. If you look at the profit also, I think they have delivered around adjusting for the exceptions that they have done around Rs 550 crore is the part of the provisioning or a claim on the Protonix, they have created that provision during the particular quarter. So adjusted for that, I think Rs 890-900 crore is definitely very strong number that has been delivered.”

Buy, Hold, Sell ? Hear it first on M3
Buy Ranbaxy Labs, target of Rs 620-630: Vivek Kumar

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login